Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

New application of cistanche polysaccharides and pharmaceutical composition with same

A technology of cistanche polysaccharide and composition, applied in the field of medicine

Inactive Publication Date: 2018-09-14
TIANJIN UNIV OF TRADITIONAL CHINESE MEDICINE
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0013] Tu Pengfei's research group used the HPLC-UV method to study the metabolism of echinacoside in vivo, and found that its pharmacokinetics conformed to the characteristics of a one-compartment model after intragastric administration (100mg / kg), and the peak time was 15.0min, but The peak concentration is only (612.2±320.4) ng / mL, and the absolute bioavailability is only 0.83% [27]

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • New application of cistanche polysaccharides and pharmaceutical composition with same
  • New application of cistanche polysaccharides and pharmaceutical composition with same
  • New application of cistanche polysaccharides and pharmaceutical composition with same

Examples

Experimental program
Comparison scheme
Effect test

preparation example 1

[0233] Preparation Example 1: Preparation of Crude Cistanche Cistanche Cistanche Phenylethanol Glycoside (PHE)

[0234] Take 3kg slices of Cistanche deserticola medicinal material, dry and pulverize into coarse powder, and use 85% ethanol (volume percentage concentration, the same below) successively, and the ratio of solid to liquid (unit is kg:L, the same below) is 1:12, 1:12 respectively. 10. Extract twice at 60°C, 2 hours each time, and combine the extracts. The dregs are used in Preparation Example 2 below.

preparation example 2

[0235] After the extract was concentrated under reduced pressure, it was separated by HPD300 macroporous adsorption resin, and eluted with water, 10% ethanol, and 50% ethanol in sequence. The elution flow rate was 1.5 column volumes / hour, and each gradient eluted 4 column volumes.

[0236] The fractions eluted with 50% ethanol were collected, concentrated under reduced pressure and then freeze-dried to obtain 50 g of crude extract of phenylethanol glycosides from Cistanche deserticola (abbreviated as PHE).

[0237] Preparation example 2: preparation of Cistanche total sugar (ZT)

[0238] After the dregs of Preparation Example 1 were evaporated to dry ethanol, they were extracted with boiling water at 100°C, and the ratio of solid to liquid was 1:12 and 1:10 respectively, and the extracts were extracted twice for 2 hours each time, and the extracts were combined.

[0239] After the extract was concentrated under reduced pressure, 95% ethanol was added under constant stirring ...

preparation example 3

[0240] Preparation Example 3: Preparation of Cistanche High Molecular Weight Polysaccharide Extract (HM)

[0241] Get the cistanche total sugar (ZT) sample 245g that preparation example 2 makes, be made into 2% aqueous solution, use molecular weight cut-off to be 100kDa hollow fiber ultrafiltration membrane ultrafiltration, can not pass through the part of 100k hollow fiber ultrafiltration membrane, concentrate freeze-drying Finally, 73 g of high molecular weight segment polysaccharide extract (molecular weight greater than 100,000, referred to as HM) was obtained.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Molecular weightaaaaaaaaaa
Peak molecular weightaaaaaaaaaa
Peak molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention belongs to the field of medicines, and relates to a new application of cistanche polysaccharides and a pharmaceutical composition with the same, in particular to application of cistanchepolysaccharides for preparation of a medicament for promoting in vivo absorption of phenylethanoid glycosides. The invention also relates to a pharmaceutical composition containing cistanche polysaccharides as an active ingredient, a phenylethanoid glycoside compound and / or a plant extract containing a phenylethanoid glycoside compound. Cistanche polysaccharides can effectively promote the in vivo absorption of phenylethanoid glycosides. The pharmaceutical composition disclosed by the invention has an estrogen-like action and is effective for treating and / or preventing osteoporosis.

Description

technical field [0001] The invention belongs to the field of medicine, and relates to a new application of cistanche polysaccharide and a pharmaceutical composition containing the cistanche polysaccharide. Background technique [0002] Cistanche deserticola (Cistanche deserticola) is the dry fleshy stem with scales of Cistanche deserticola (Cistanche deserticola Y.C.Ma) or C. tubulosa (Schrenk) Wight. It is mainly produced in arid and semi-arid regions of China , Such as: Inner Mongolia, Xinjiang, Gansu, Ningxia, Qinghai and other places, it is known as "desert ginseng". There are 8 species and 1 variety of Cistanche in my country, namely C.deserticola Y.C.Ma(Cd), C.tubulosa(Schrenk)Wight(Ct), C.salsa(C.A.Mey)G.Beck (Csa), C.sinensis G.Beck(Csi), C.lanzhouensis Z.Y.Zhang, C.ambigua(Bge.)G.Beck, C.fissa(C.A.Mey)G. Beck, C. ningxiaensis D.Z.Maet A.Duan and C.salsa var.albiflora P.F.Tu et Z.C.Lou [1,2] . [0003] Cistanche deserticola is sweet, salty and warm in nature and fl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/715A61K31/716A61K31/7032A61K36/64A61P19/10A61P5/30
CPCA61K31/715A61K31/7032A61K31/716A61K36/64A61P5/30A61P19/10A61K2300/00
Inventor 高秀梅付志飞刘二伟赵鑫毛浩萍王小莹
Owner TIANJIN UNIV OF TRADITIONAL CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products